pubmed-article:19954977 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0596402 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0012920 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0034255 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C1522290 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:19954977 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:19954977 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19954977 | pubmed:dateCreated | 2010-2-3 | lld:pubmed |
pubmed-article:19954977 | pubmed:abstractText | For the development of novel antitumor agents, 2,6-dithienyl-4-furyl pyridine derivatives were prepared and evaluated for their topoisomerase I and II inhibitory activity as well as cytotoxicity against several human cancer cell lines. Among the 21 prepared compounds, compound 24 exhibited strong topoisomerase I inhibitory activity. In addition, a docking study with topoisomerase I and compound 24 was performed. | lld:pubmed |
pubmed-article:19954977 | pubmed:language | eng | lld:pubmed |
pubmed-article:19954977 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19954977 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19954977 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19954977 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:LeeEung-SeokE... | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:KwonYoungjooY | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:NaYounghwaY | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:ChoWon-JeaWJ | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:JeongByeong-S... | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:LeeChong-Soon... | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:JahngYurngdon... | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:BasnetArjunA | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:ChoiHoyoungH | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:ThapaPritamP | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:KarkiRadhaR | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:ChoiJae HunJH | lld:pubmed |
pubmed-article:19954977 | pubmed:author | pubmed-author:YunMinhoM | lld:pubmed |
pubmed-article:19954977 | pubmed:copyrightInfo | Copyright 2009 Elsevier Ltd. All rights reserved. | lld:pubmed |
pubmed-article:19954977 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19954977 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19954977 | pubmed:volume | 20 | lld:pubmed |
pubmed-article:19954977 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19954977 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19954977 | pubmed:pagination | 42-7 | lld:pubmed |
pubmed-article:19954977 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:meshHeading | pubmed-meshheading:19954977... | lld:pubmed |
pubmed-article:19954977 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:19954977 | pubmed:articleTitle | 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. | lld:pubmed |
pubmed-article:19954977 | pubmed:affiliation | College of Pharmacy, Yeungnam University, Kyongsan 712-749, Republic of Korea. | lld:pubmed |
pubmed-article:19954977 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19954977 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19954977 | lld:chembl |